Pharmaceutical

TheracosBio and BAMCO to bring BRENZAVVY to sub-Saharan Africa for T2D

TheracosBio has entered a partnership with BAMCO Africa to deliver BRENZAVVY (bexagliflozin) to patients in sub-Saharan Africa.

Oct 20, 2024 - 04:00
TheracosBio and BAMCO to bring BRENZAVVY to sub-Saharan Africa for T2D
TheracosBio has entered a partnership with BAMCO Africa to deliver BRENZAVVY (bexagliflozin) to patients in sub-Saharan Africa.
Read the original article

Tags:

Previous Article

mRNA licensing agreements surge 800% amid GSK lawsuits

Next Article

Unresolved clawback issues obstruct Greece’s potential pharmaceutical framework ...

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Genentech review of Tessier-Lavigne paper finds no evidence of fraud — but hints at a different misconduct case

Genentech review of Tessier-Lavigne paper finds no evid...

Apr 7, 2023

STAT+: Health plan formularies lowered barriers to fair access to some drugs, analysis finds

STAT+: Health plan formularies lowered barriers to fair...

Nov 3, 2023

Latozinemab by Alector for Frontotemporal Dementia (FTD): Likelihood of Approval

Latozinemab by Alector for Frontotemporal Dementia (FTD...

Dec 4, 2023